Europe ePRO, ePatient Diaries, and eCOA Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type of Solution, EPROs, ClinROs, ObsROs, PerfOs, and ePatient Diaries; Modality; End User, Hospitals, Academic Institutes, Pharmaceutical Companies, and Others

e-Clinical Outcome Assessments Segment has the Largest Share of Type of Solution in the Europe ePRO, ePatient Diaries, and eCOA Market during 2021-2028

According to this research study titled “Europe ePRO, ePatient Diaries, and eCOA Market to 2028 - COVID-19 Impact and Regional Analysis and Forecast by Type of Solution, Modality, and End User,” the market is expected to reach US$ 1,184.3 million by 2028 from US$ 447.8 million in 2021. The market is estimated to grow at a CAGR of 14.9% from 2021 to 2028. The report provides trends prevailing in the Europe ePRO, ePatient Diaries, and eCOA market along with the drivers and restraints pertaining to the market growth. The growth of this market is estimated to grow owing to key driving factors such as the increasing demand for electronic health records (EHRs), rising use of smartphones and growing demand for clinical trials are the key factors driving the market growth. However, the market is expected experiencing slow growth during the forecast period owing to the concerns regarding data privacy.

Short-term impacts of the COVID-19 pandemic include demand changes, revision in the regulatory process, changes in the research and development process, and the shift towards telecommunication and telemedicine. Moreover, the slowdown in market growth, delay in product approval, adoption of the self-sufficient pharm-production supply chain, and changes in the trend in consumption of health-market products and ethical dilemmas could be anticipated as long-term impacts of the COVID-19 pandemic on the pharmaceutical sector in both global and local levels. Market players in the market are launching new software platforms to boost electronic clinical trials to deal with a pandemic situation. For instance, In July 2020, Axiom Real-Time Metrics (“Axiom”), a leading provider of unified eClinical technologies and services, announced its collaboration with the University of Oxford on a large-scale clinical trial on COVID-19 preventative treatments. These factors had a potential impact on the Europe ePRO, e-Patient Diaries, and eCOA market.

The market for ePRO, ePatient Diaries, and eCOA market is segmented into type of solution, modality, and end user. In 2020, the eCOA (Electronic Clinical Outcome Assessments) segment accounted for the Europe ePRO, ePatient diaries, and eCOA market's largest market share. This large share can be attributed to the advantages offered by eCOA, as eCOA uses technology such as smartphones, laptops, computers to enable patients, nurses, and doctors to consult directly about medical test results. ECOA provides highly accurate knowledge that better understands and simplifies the acceptance process for patient reviews in clinical trials. In addition, the increasing cost for pharmaceutical manufacturers of modern overall drug development methodologies has led to their use of electronic information collection by way of paper-based processes. Data processing across eCOA networks improves the quality of the information gathered, harmonizes data systems, and gives users valuable benefits, such as data interpretation.

ERT Clinical, ArisGlobal LLC, The Diary Pte. Ltd, ICON PLC, PAREXEL INTERNATIONAL CORPORATION, Anju Software, Inc., Kayentis, Bracket Global LLC, Dassault Systèmes SE, and CRF Health are among the leading companies in the Europe ePRO, ePatient Diaries, and eCOA market. The companies are focused on adopting organic growth strategies such as product launches and expansions to sustain their position in the dynamic market. For instance, in February 2021, ERT, announced a powerful new solution for enabling the collection, processing and analysis of photos and audio as part of clinical trial eCOA assessments. This solution promises to streamline and drive patient compliance with data collection, while safeguarding patient privacy, confidentiality, and data security.

The report segments the Europe EPRO, ePatient Diaries, and eCOA market as follows:

By Type of Solution

• eClinical Outcome Assessments
• e-Patient Reported Outcomes
• Clinician Reported Outcomes
• Observer Reported Outcomes
• Performance Outcomes
• e-Patient Diaries

By Modality

• Computer
• Mobile Devices

By End User

• Clinical Trial Sponsors
• Contract Research Organizations
• Hospitals
• Academic Institutes
• Pharmaceutical Companies
• Others

By Country

• Europe - Germany
• UK
• France
• Spain
• Italy
• Rest of Europe